Gulf War and Health: Volume 1: Depleted Uranium, Sarin, Pyridostigmine Bromide, and Vaccines (2000)
Chapter: Appendix A: Scientific Workshop Agenda
A
Scientific Workshop Agenda
INSTITUTE OF MEDICINE
NATIONAL ACADEMY OF SCIENCES
Committee on Health Effects Associated with Exposures During the Gulf War
June 14–15, 1999
Cecil and Ida Green Building, Room 126
2001 Wisconsin Avenue N.W., Washington, D.C.
MONDAY, JUNE 14, 1999
|
8:15–8:30 a.m. |
Opening Remarks Harold Sox, M.D. (Chair) |
|
8:30–9:00 a.m. |
War Syndromes and Their Evaluation Craig Hyams, M.D., M.P.H. Naval Medical Research Center |
|
9:00–10:00 a.m. |
Epidemiologic Studies on Gulf War Veterans |
|
9:00–9:30 a.m. |
The Iowa Persian Gulf Study Bradley Doebbeling, M.D. University of Iowa College of Medicine |
|
9:30–10:00 a.m. |
Health Study of Canadian Forces Personnel Lesbia F. Smith, M.D. Department of Public Health Sciences, University of Toronto |
|
10:00–10:30 a.m. |
Health Effects of Depleted Uranium David McClain, Ph.D. Armed Forces Radiobiology Research Institute |
|
10:30–11:15 a.m. |
Pentavalent Botulinum Toxoid: Human Clinical Safety—30 Years of Experience at a Biological Laboratory |
|
|
Anthrax Vaccine: Human Safety Data—25 years of Experience at USAMRIID and the Safety of a Recent Human Dose Reduction Study Phillip Pittman, M.D., M.P.H. U.S. Army Medical Research Institute of Infectious Diseases |
|
11:15–11:45 p.m. |
IOM study Veterans and Agent Orange, Methodology Andrew Olshan, Ph.D. School of Public Health, University of North Carolina at Chapel Hill |
|
11:45–12:15 p.m. |
Genetic Susceptibility James Hanson, M.D. National Cancer Institute |
|
12:15–12:45 p.m. |
Lunch |
|
12:45–1:15 p.m. |
Chemical Interactions: Pyridostigmine Bromide, DEET, and Permethrin Mohamed Abou-Donia, Ph.D. Duke University Medical Center |
|
1:15–1:45 p.m. |
PB and Growth Hormone Keith Friend, M.D. M.D. Anderson Cancer Center |
|
1:45–2:30 p.m. |
Biological Effects of Stress William Malarkey, M.D. Ohio State University |
|
2:30–3:30 p.m. |
Toxicant-Induced Loss of Tolerance Claudia Miller, M.D., M.S. University of Texas Health Science Center at San Antonio |
|
3:30–4:00 p.m. |
Chemical Interactions Ernest Hodgson, Ph.D. North Carolina State University |
|
4:00–5:00 p.m. |
Plenary Session |
|
5:00 p.m. |
Adjourn |
TUESDAY, JUNE 15, 1999
|
1:30–2:00 p.m. |
Exposure Assessment Issues Demetrios Moschandreas, Ph.D. (committee member) Illinois Institute of Technology |
|
2:00–2:30 p.m. |
Methodological Issues Charles Phelps, Ph.D. (committee member) University of Rochester |
|
2:30–3:00 p.m. |
Anthrax Vaccine Philip Brachman, M.D. Rollins School of Public Health, Emory University |
